Blog

​In vitro transcription (IVT) has become the foundational manufacturing technology for modern mRNA-based modalities, including prophylactic vaccines, cancer immunotherapies, protein replacement agents, in vivo cell therapies and gene editing systems. Despite widespread adoption, lab-scale mRNA synthesis continues to face persistent technical challenges: